help button home button ClinMed NetPrints
HOME HELP FEEDBACK BROWSE ARTICLES BROWSE BY AUTHOR
Warning: This article has not yet been accepted for publication by a peer reviewed journal. It is presented here mainly for the benefit of fellow researchers. Casual readers should not act on its findings, and journalists should be wary of reporting them.

This Article
Right arrow Full Text
Services
Right arrow Similar articles in this netprints
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferriter, M.
Right arrow Articles by Travers, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ferriter, M.
Right arrow Articles by Travers, R.
Related Collections
Right arrow Psychiatry:
Anxiety

Right arrow Posttraumatic Stress Disorder
Right arrow Other Psychiatry
Right arrow Drugs: psychiatry
Right arrow Statistics and Research Methods:
Systematic reviews (incl meta-analyses): examples

clinmed/2003090010v1 (September 23, 2003)
Contact author(s) for copyright information

Risperidone as a treatment for symptoms associated with Post-Traumatic Stress Disorder and Acute Stress Reaction/Disorder. A systematic review.

Michael Ferriter, Paul Mooney, and Raymond Travers

Background: Exposure to traumatic events accounts for a significant amount of psychological morbidity in the population. The resulting psychological disorder can be acute and time limited (Acute Stress Reaction/Disorder) or chronic (Post-Traumatic Stress Disorder). The traditional approach to these disorders has been through a range of ‘talking’ therapies though there is, at best, a limited evidence base to support their use and in one form of therapy (psychological debriefing) evidence that contraindicates its use. In contrast, the use of pharmacological therapies is a growing area of research. Risperidone is known to impact on both the serotonergic and dopaminergic neurotransmitter systems that research has shown to be altered in Post-Traumatic Stress Disorder. The purpose of this review was to see what evidence there was to support the use of risperidone in the treatment of stress disorders. Method: The relevant databases were searched for suitable studies concerning risperidone treatment of PTSD. Results: The results of the search were disappointing, discovering only one, unpublished, RCT, four case series and two case reports. Conclusion: The evidence was generally in favour of the intervention but of insufficient quantity or quality to make recommendations for clinical practice. However, this is clearly a promising area for research and there is a compelling humanitarian and economic case to carry out better and larger scale trials on risperidone and other pharmacological interventions both as an adjunct and an alternative to traditional psychological approaches.





HOME HELP FEEDBACK BROWSE ARTICLES BROWSE BY AUTHOR